Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation
Mental Health Clinician · 2026-06 · 16 (3) · 141-149
DOI: 10.9740/mhc.2026.06.141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mental Health Clinician, 2026-06. Verfasst von Michael R Dueno und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky College of Pharmacy, Lexington, Kentucky. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
When discontinuing benzodiazepines, treating withdrawal symptoms can be challenging. Some anti-seizure medications (ASM) may mitigate withdrawal symptoms. This article reviews the literature regarding adjunctive ASM use during benzodiazepine tapering and discontinuation.
Methods
A PubMed search focusing on the use of ASMs as adjunctive agents to mitigate benzodiazepine withdrawal symptoms was conducted. Key search teams identified relevant articles, and the references of included articles were evaluated to identify potential additional publications for inclusion. In total, 21 articles met the inclusion criteria, and 44 articles were excluded for various reasons.
Results
Several clinical trials, observational studies, case reports, and case series were identified. Carbamazepine was more effective than placebo at 3 months (74% benzodiazepine free vs 52% for placebo). Oxcarbazepine enabled successful rapid detoxification with minimal withdrawal symptoms in a small, noncontrolled study. Valproate, pregabalin, and gabapentin showed improvements in benzodiazepine-free rates, but the results were inconsistent.
Discussion
Evidence for ASM in benzodiazepine withdrawal is limited, emphasizing the need for provider discretion. Additional larger clinical trials are warranted to identify optimal agents to mitigate withdrawal symptoms and enhance successful benzodiazepine cessation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Kentucky College of Pharmacy, Lexington, Kentucky.
- (Corresponding author) Associate Professor & Emergency Medicine Pharmacist, University of Kentucky College of Pharmacy, and University of Kentucky HealthCare, Lexington, Kentucky, gavin.howington@uky.edu.
- Professor, University of Kentucky College of Pharmacy, Lexington, Kentucky.
ORCID-Profile: Michael R Dueno, Gavin T Howington, Melody Ryan
Zitieren
APA
Dueno, M. R., Howington, G. T., & Ryan, M. (2026). Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. Mental Health Clinician, 16(3), 141-149. https://doi.org/10.9740/mhc.2026.06.141
Vancouver
Dueno MR, Howington GT, Ryan M. Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. Mental Health Clinician. 2026;16(3):141-149. doi:10.9740/mhc.2026.06.141
BibTeX
@article{Dueno2026,
author = {Dueno, Michael R and Howington, Gavin T and Ryan, Melody},
title = {Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation},
journal = {Mental Health Clinician},
year = {2026},
volume = {16},
number = {3},
pages = {141--149},
doi = {10.9740/mhc.2026.06.141}
}
EUVIMED